Cefscan-T 281.25mg Injection
Marketer
Medishri Healthcare
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cefscan-T 281.25mg Injection
Cefscan-T 281.25mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration requires strict medical oversight; missed doses should be avoided, and the full treatment regimen must be completed, regardless of symptom improvement. Premature cessation may compromise efficacy. Minor side effects, including nausea, vomiting, diarrhea, and dyspepsia, may occur. Severe side effects warrant immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) require emergency care. Inform your physician about all current medications, especially if pregnant or breastfeeding. Alcohol should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are crucial for optimal recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Cefscan-T 281.25mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Cefscan-T 281.25mg Injection
Infections caused by bacteria
Major Benefits of Cefscan-T 281.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cefscan-T 281.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefscan-T 281.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cefscan-T 281.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Cefscan-T 281.25mg Injection, offer a targeted antibacterial approach. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cefscan-T 281.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefscan-T 281.25mg injections are typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
The administration of Cefscan-T 281.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefscan-T 281.25mg Injection could lead to drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Cefscan-T 281.25mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Administering Cefscan-T 281.25mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Cefscan-T 281.25mg Injection are generally unadvised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Cefscan-T 281.25mg Injection :
Omit a Cefscan-T 281.25mg Injection dose? Seek your physician's advice.
Facts to Know About Cefscan-T 281.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently